|
RU2494108C2
(ru)
|
2006-04-07 |
2013-09-27 |
Аерпио Терапетикс, Инк. |
Антитела, которые связывают человеческий белок бета-тирозин фосфатазу (нртрвета), и их использование
|
|
WO2013056240A1
(en)
|
2011-10-13 |
2013-04-18 |
Aerpio Therapeutics, Inc. |
Methods for treating vascular leak syndrome and cancer
|
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
|
KR102669985B1
(ko)
|
2015-06-30 |
2024-05-29 |
샌포드 번햄 프레비즈 메디컬 디스커버리 인스티튜트 |
Btla 융합 단백질 작용제 및 이의 용도
|
|
KR20250057128A
(ko)
|
2015-12-30 |
2025-04-28 |
코디악 사이언시스 인코포레이티드 |
항체 및 이의 접합체
|
|
CN109843327B
(zh)
|
2016-07-07 |
2022-05-13 |
小利兰·斯坦福大学托管委员会 |
抗体佐剂缀合物
|
|
ES2965352T3
(es)
|
2017-05-30 |
2024-04-12 |
Bristol Myers Squibb Co |
Tratamiento de tumores positivos a gen 3 de activación de linfocitos (LAG-3)
|
|
CN110678200B
(zh)
|
2017-05-30 |
2024-05-17 |
百时美施贵宝公司 |
包含抗lag-3抗体或抗lag-3抗体和抗pd-1或抗pd-l1抗体的组合物
|
|
EP3758737A4
(en)
|
2018-03-02 |
2022-10-12 |
Kodiak Sciences Inc. |
IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF
|
|
WO2020068653A1
(en)
|
2018-09-24 |
2020-04-02 |
Aerpio Pharmaceuticals, Inc. |
MULTISPECIFIC ANTIBODIES THAT TARGET HPTP - β (VE-PTP) AND VEGF
|
|
EP3908664A4
(en)
*
|
2019-01-07 |
2023-01-25 |
Thomas Jefferson University |
MULTIFUNCTIONAL FUSION PROTEINS AND THEIR USES
|
|
WO2020190725A1
(en)
|
2019-03-15 |
2020-09-24 |
Bolt Biotherapeutics, Inc. |
Immunoconjugates targeting her2
|
|
JP7805788B2
(ja)
*
|
2019-05-23 |
2026-01-26 |
ヤンセン バイオテツク，インコーポレーテツド |
Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
|
|
BR112021024820A2
(pt)
*
|
2019-06-10 |
2022-01-25 |
Shandong Boan Biotechnology Co Ltd |
Proteína de fusão bifuncional contra pdl1 e tgfss e uso da mesma
|
|
WO2020252421A2
(en)
*
|
2019-06-14 |
2020-12-17 |
Cugene, Inc. |
Novel interleukin-2 variants and bifunctional fusion molecules thereof
|
|
WO2020257196A1
(en)
*
|
2019-06-17 |
2020-12-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of treating infections by blocking pathogen mimics of cd47
|
|
US20210107969A1
(en)
*
|
2019-07-09 |
2021-04-15 |
The Johns Hopkins University |
Molecules, compositions and methods for treatment of cancer
|
|
CN110627905B
(zh)
*
|
2019-09-18 |
2021-04-27 |
中国医学科学院肿瘤医院 |
靶向vegf与egfr的双功能融合蛋白及其应用
|
|
WO2021055994A1
(en)
*
|
2019-09-22 |
2021-03-25 |
Bristol-Myers Squibb Company |
Quantitative spatial profiling for lag-3 antagonist therapy
|
|
CN112574314A
(zh)
*
|
2019-09-30 |
2021-03-30 |
和铂医药(苏州)有限公司 |
一种融合蛋白及其应用
|
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
US20220411499A1
(en)
*
|
2019-11-08 |
2022-12-29 |
Bristol-Myers Squibb Company |
LAG-3 Antagonist Therapy for Melanoma
|
|
BR112022010824A2
(pt)
*
|
2019-12-11 |
2022-08-23 |
Wuxi Biologics Ireland Ltd |
Anticorpo bifuncional contra pd-l1 e tgf¿
|
|
JP7730817B6
(ja)
*
|
2019-12-20 |
2025-09-26 |
アレス トレーディング ソシエテ アノニム |
ＩｇＧ：ＴＧＦβＲＩＩ融合タンパク質組成物
|
|
US11045546B1
(en)
|
2020-03-30 |
2021-06-29 |
Cytodyn Inc. |
Methods of treating coronavirus infection
|
|
BR112022022020A2
(pt)
*
|
2020-04-29 |
2023-01-31 |
Chia Tai Tianqing Pharmaceutical Group Co Ltd |
Proteína bifuncional contra pd-1 e tgf-ss
|
|
US20210347880A1
(en)
*
|
2020-05-05 |
2021-11-11 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
|
IL298136A
(en)
|
2020-05-13 |
2023-01-01 |
Bonum Therapeutics Inc |
Preparations of protein complexes and methods of using them
|
|
IL298389A
(en)
|
2020-05-21 |
2023-01-01 |
Janssen Biotech Inc |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
|
|
JP2023532279A
(ja)
*
|
2020-06-26 |
2023-07-27 |
ソレント・セラピューティクス・インコーポレイテッド |
免疫調節性融合タンパク質を発現する腫瘍溶解性単純ヘルペスウイルス（ｈｓｖ）
|
|
WO2022013745A1
(en)
*
|
2020-07-13 |
2022-01-20 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody
|
|
CN116261448A
(zh)
*
|
2020-08-19 |
2023-06-13 |
百奥泰生物制药股份有限公司 |
用于治疗il-6相关疾病的包含高浓度人源化抗体的液体制剂
|
|
KR20230093282A
(ko)
|
2020-10-23 |
2023-06-27 |
브리스톨-마이어스 스큅 컴퍼니 |
폐암에 대한 lag-3 길항제 요법
|
|
CN114539415B
(zh)
*
|
2020-11-24 |
2024-02-02 |
普米斯生物技术(珠海)有限公司 |
一种抗PD-L1/VEGF/TGF-β多特异性抗体及其用途
|
|
AU2021389989A1
(en)
*
|
2020-11-27 |
2023-06-08 |
Elpiscience (Suzhou) Biopharma, Ltd. |
Novel conjugate molecules targeting cd39 and tgfβeta
|
|
KR20230150858A
(ko)
*
|
2021-02-27 |
2023-10-31 |
엘루미넥스 바이오사이언시스 (쑤저우) 리미티드 |
Il-6 수용체 및 혈관신생 인자를 표적화하는 항체 융합 단백질
|
|
EP4305062A1
(en)
*
|
2021-03-12 |
2024-01-17 |
Janssen Biotech, Inc. |
Method of treating psoriatic arthritis patients with inadequate response to tnf therapy with anti-il23 specific antibody
|
|
IL305802A
(en)
*
|
2021-03-12 |
2023-11-01 |
Janssen Biotech Inc |
A safe and effective method for the treatment of rheumatoid arthritis with a specific anti-IL23 antibody
|
|
CN113698493B
(zh)
*
|
2021-08-09 |
2022-05-31 |
北京东方百泰生物科技股份有限公司 |
一种针对VEGF和TGF-β的双功能蛋白及其应用
|
|
WO2023083381A1
(zh)
|
2021-11-15 |
2023-05-19 |
成都百利多特生物药业有限责任公司 |
双特异性抗体-喜树碱类药物偶联物及其医药用途
|
|
US20250115658A1
(en)
*
|
2022-01-31 |
2025-04-10 |
Fbd Biologics Limited |
Engineered pd-1 variants and methods of use thereof
|
|
EP4249510A1
(en)
*
|
2022-03-22 |
2023-09-27 |
Stealth IO |
Novel formats of anti-cd28/spd-1 fusion constructs
|
|
CN117624375A
(zh)
*
|
2022-08-30 |
2024-03-01 |
北京卡替医疗技术有限公司 |
增强受体、表达增强受体的免疫细胞及其用途
|
|
CN116554300B
(zh)
*
|
2023-04-27 |
2023-10-24 |
湖北医药学院 |
一种能与艰难拟梭菌毒素TcdB相互作用的多肽及其应用
|
|
WO2026085300A1
(en)
*
|
2024-10-16 |
2026-04-23 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods
|